Evaluation of the "Burgenland PREvention trial of colorectal cancer Disease with ImmunologiCal Testing" (B-PREDICT)-a population-based colorectal cancer screening program

被引:0
作者
Brezina, Stefanie [1 ]
Leeb, Gernot [2 ]
Baierl, Andreas [3 ]
Graef, Evelyn [4 ]
Hackl, Monika [5 ]
Hofer, Philipp [6 ]
Lang, Harald [7 ]
Klein, Michaela [8 ]
Mach, Karl [2 ]
Schwarzer, Remy [9 ]
Wlassits, Wilhelm [2 ]
Puespoek, Andreas [9 ]
Gsur, Andrea [1 ]
机构
[1] Med Univ Vienna, Ctr Canc Res, Borschkegasse 8a, A-1090 Vienna, Austria
[2] Hosp Oberpullendorf, Dept Internal Med, Oberpullendorf, Austria
[3] Univ Vienna, Dept Stat & Operat Res, Vienna, Austria
[4] Inst Clin Pathol & Microbiol, Oberwart, Austria
[5] Stat Austria, Vienna, Austria
[6] Med Univ Vienna, Dept Pathol, Vienna, Austria
[7] Outpatient Clin Med & Chem Lab Diagnost, Eisenstadt, Austria
[8] Austrian Canc Aid Burgenland, Bad Sauerbrunn, Austria
[9] St Johns Hosp, Dept Internal Med 2, Eisenstadt, Austria
关键词
Colorectal cancer; Two-stage screening; FIT; OCCULT BLOOD-TEST; COLONOSCOPY; QUALITY; STRATEGIES; DIAGNOSIS; TRENDS; TIME;
D O I
10.1186/s12876-024-03242-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background The colorectal cancer (CRC) screening program B-PREDICT is a population based invited two stage screening project using a faecal immunochemical test (FIT) for initial screening followed by a colonoscopy for those with a positive FIT. B-PREDICT was compared with the opportunistic screening colonoscopy (OPP-COL), performed in course of the nationwide screening program. Methods Within B-PREDICT all residents of the Austrian federal state Burgenland, aged between 40 and 80 are annually invited to FIT testing. All individuals who underwent initial colonoscopy in Burgenland between 01/2003 and 12/2014, were included in this study. Individuals from the FIT-triggered invited screening program B-PREDICT were compared with those from the non-FIT triggered OPP-COL. Results 15 133 individuals from B-PREDICT were compared to 10 045 individuals with OPP-COL. CRC detection rates were 1.34% (CI-95%, [1.15; 1.52]) in B-PREDICT compared to 0.54% in OPP-COL (95%-CI, [0.39; 0.68] p<0.001). The decrease in the age standardized incidence rates of CRC was more pronounced in the population screened with FIT than in the general population screened with colonoscopy. Changes in incidence rates per year were -4.4% (95%-CI, [-5.1; -3.7]) vs. -1.8% (95%-CI, [-1.9; -1.6] p<0.001). Conclusions B-PREDICT shows a two-fold higher detection rate of CRC as well as HRA compared to OPP-COL.
引用
收藏
页数:9
相关论文
共 32 条
[1]   Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial [J].
Atkin, Wendy S. ;
Edwards, Rob ;
Kralj-Hans, Ines ;
Wooldrage, Kate ;
Hart, Andrew R. ;
Northover, John M. A. ;
Parkin, D. Max ;
Wardle, Jane ;
Duffy, Stephen W. ;
Cuzick, Jack .
LANCET, 2010, 375 (9726) :1624-1633
[2]  
AUSTRIA S, 2013, Osterreichisches Krebsregister. Stand 19.12.2019 und Todesursachenstatistik
[3]   Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study [J].
Breekveldt, Emilie C. H. ;
Lansdorp-Vogelaar, Iris ;
Toes-Zoutendijk, Esther ;
Spaander, Manon C. W. ;
van Vuuren, Anneke J. ;
van Kemenade, Folkert J. ;
Ramakers, Christian R. B. ;
Dekker, Evelien ;
Nagtegaal, Iris ;
Krul, Myrtle F. ;
Kok, Niels F. M. ;
Kuhlmann, Koert F. D. ;
Vink, Geraldine R. ;
van Leerdam, Monique E. ;
Elferink, Marloes A. G. .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (01) :60-68
[4]   The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention [J].
Brenner, Hermann ;
Chen, Chen .
BRITISH JOURNAL OF CANCER, 2018, 119 (07) :785-792
[5]   An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer [J].
Burnett-Hartman, Andrea N. ;
Lee, Jeffrey K. ;
Demb, Joshua ;
Gupta, Samir .
GASTROENTEROLOGY, 2021, 160 (04) :1041-1049
[6]   Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis [J].
Corley, Douglas A. ;
Jensen, Christopher D. ;
Quinn, Virginia P. ;
Doubeni, Chyke A. ;
Zauber, Ann G. ;
Lee, Jeffrey K. ;
Schottinger, Joanne E. ;
Marks, Amy R. ;
Zhao, Wei K. ;
Ghai, Nirupa R. ;
Lee, Alexander T. ;
Contreras, Richard ;
Quesenberry, Charles P. ;
Fireman, Bruce H. ;
Levin, Theodore R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (16) :1631-1641
[7]   Sex-Specific Prevalence of Adenomas, Advanced Adenomas, and Colorectal Cancer in Individuals Undergoing Screening Colonoscopy [J].
Ferlitsch, Monika ;
Reinhart, Karoline ;
Pramhas, Sibylle ;
Wiener, Caspar ;
Gal, Orsolya ;
Bannert, Christina ;
Hassler, Michaela ;
Kozbial, Karin ;
Dunkler, Daniela ;
Trauner, Michael ;
Weiss, Werner .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (12) :1352-1358
[8]  
Frschl BAK., 2016, bersicht nationaler Kolonkrebs-Screening-Programme
[9]   Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? [J].
Grazzini, G. ;
Visioli, C. B. ;
Zorzi, M. ;
Ciatto, S. ;
Banovich, F. ;
Bonanomi, A. G. ;
Bortoli, A. ;
Castiglione, G. ;
Cazzola, L. ;
Confortini, M. ;
Mantellini, P. ;
Rubeca, T. ;
Zappa, M. .
BRITISH JOURNAL OF CANCER, 2009, 100 (02) :259-265
[10]   Meeting report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer [J].
Gunter, M. J. ;
Alhomoud, S. ;
Arnold, M. ;
Brenner, H. ;
Burn, J. ;
Casey, G. ;
Chan, A. T. ;
Cross, A. J. ;
Giovannucci, E. ;
Hoover, R. ;
Houlston, R. ;
Jenkins, M. ;
Laurent-Puig, P. ;
Peters, U. ;
Ransohoff, D. ;
Riboli, E. ;
Sinha, R. ;
Stadler, Z. K. ;
Brennan, P. ;
Chanock, S. J. .
ANNALS OF ONCOLOGY, 2019, 30 (04) :510-519